MPLN Stock Overview
Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
MultiPlan Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.45 |
| 52 Week High | US$69.20 |
| 52 Week Low | US$4.80 |
| Beta | 0.64 |
| 11 Month Change | -41.47% |
| 3 Month Change | -35.50% |
| 1 Year Change | -87.50% |
| 33 Year Change | -96.33% |
| 5 Year Change | n/a |
| Change since IPO | -98.34% |
Recent News & Updates
Recent updates
MultiPlan Corporation (NYSE:MPLN) Shares Fly 55% But Investors Aren't Buying For Growth
Oct 20
MultiPlan Corporation (NYSE:MPLN) Not Doing Enough For Some Investors As Its Shares Slump 40%
Aug 18Little Excitement Around MultiPlan Corporation's (NYSE:MPLN) Revenues As Shares Take 46% Pounding
Jul 04MultiPlan (NYSE:MPLN) Use Of Debt Could Be Considered Risky
Jul 02MultiPlan Corporation (NYSE:MPLN) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
May 09Estimating The Intrinsic Value Of MultiPlan Corporation (NYSE:MPLN)
Apr 23Why Investors Shouldn't Be Surprised By MultiPlan Corporation's (NYSE:MPLN) 26% Share Price Plunge
Mar 13MultiPlan (NYSE:MPLN) Has A Somewhat Strained Balance Sheet
Mar 05Insufficient Growth At MultiPlan Corporation (NYSE:MPLN) Hampers Share Price
Jan 08MultiPlan Sees Uptick In Utilization But Revenue Growth Is A Challenge
Oct 27Revenues Working Against MultiPlan Corporation's (NYSE:MPLN) Share Price
Oct 02MultiPlan Sees Stabilizing Markets But Contracting Revenue In 2023
Jul 13MultiPlan Corporation: Stay Away From The Stock In The Near Term
Jan 07MultiPlan Corporation (NYSE:MPLN) Analysts Just Trimmed Their Revenue Forecasts By 15%
Nov 18Multiplan Corporation GAAP EPS of $0.03 in-line, revenue of $250.5M misses by $34.7M
Nov 08MultiPlan Corporation: Adding This Growing Healthcare Tech Play To The 'Bio Boom' Portfolio
May 23Shareholder Returns
| MPLN | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -21.6% | -8.3% | -1.0% |
| 1Y | -87.5% | 5.7% | 30.3% |
Return vs Industry: MPLN underperformed the US Healthcare Services industry which returned 7.1% over the past year.
Return vs Market: MPLN underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| MPLN volatility | |
|---|---|
| MPLN Average Weekly Movement | 17.7% |
| Healthcare Services Industry Average Movement | 8.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MPLN's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MPLN's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 2,800 | Travis Dalton | www.multiplan.us |
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars.
MultiPlan Corporation Fundamentals Summary
| MPLN fundamental statistics | |
|---|---|
| Market cap | US$84.25m |
| Earnings (TTM) | -US$1.54b |
| Revenue (TTM) | US$942.61m |
0.1x
P/S Ratio-0.1x
P/E RatioIs MPLN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MPLN income statement (TTM) | |
|---|---|
| Revenue | US$942.61m |
| Cost of Revenue | US$242.93m |
| Gross Profit | US$699.68m |
| Other Expenses | US$2.24b |
| Earnings | -US$1.54b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -95.19 |
| Gross Margin | 74.23% |
| Net Profit Margin | -163.30% |
| Debt/Equity Ratio | 2,187.2% |
How did MPLN perform over the long term?
See historical performance and comparison